Authors & review

Real, named people write and medically review our content — with credentials you can check. This page lists our authors and medical reviewers and explains how clinical content is reviewed before it carries a byline. Peptide therapy is a YMYL subject — "your money or your life" — so the bar for who stands behind a page is high.

Medical reviewers

• Clinical review — peptides, hormones, metabolic & longevity medicine Ksenia Petrushkina, PA-C, MPAS

  Ksenia Petrushkina is a board-certified physician assistant (PA-C) with a Master of Physician Assistant Studies from Florida International University. Her clinical work centers on peptide therapeutics, hormone and thyroid health, and metabolic and longevity medicine, and she is an active patient educator who emphasizes what the evidence does and does not support. She reviews PeptideWellness clinical and educational content for accuracy against prescribing information, trial data, and FDA guidance.

  Co-owner and clinician, Ideal Medical & Wellness (South Florida)

Advisors & contributors

Subject-matter advisors who review our coverage in their own field — industry practice, pharmacy operations, and regulation.

• Compounding & Industry Advisor David Bonfa

  David Bonfa is co-founder of CRE8 Pharmacy, a PCAB-accredited 503A compounding pharmacy in Florida, and president of 3AD Consulting Group, which advises compounding pharmacies and wellness clinics. He has roughly 25 years in the pharmaceutical-compounding and functional-medicine industry. At PeptideWellness he reviews our compounding and regulatory coverage for industry accuracy — how compounded medications are actually prepared, handled, stored, and quality-controlled, how 503A and 503B pharmacies operate, and whether our descriptions of that work match practice.

  Co-founder, CRE8 Pharmacy · President, 3AD Consulting Group

How medical review works

A medical reviewer reads the published version of clinical content and checks it against primary sources — prescribing labels, trial data, and FDA guidance. The review is substantive: it flags claims that overstate the evidence, language that implies efficacy a regulator hasn't established, and dosing or safety statements that aren't supported.

The standard we require

A medical reviewer must be a licensed U.S. clinician — a physician (MD/DO), physician assistant (PA-C), or nurse practitioner — holding an active, unrestricted license that is individually verifiable in a public registry (a state licensing board and/or the CMS NPI Registry), with training matched to the coverage they review. Each profile publishes the person's credential, license or NPI, and an external profile so readers can check the claim themselves. Alongside clinical review we work with subject-matter advisors in their own fields — a compounding-industry advisor, for example, who checks how we describe pharmacy practice and regulation. Their byline names the kind of review they did, and their profile lists their roles and the companies they work for.

Conflicts and independence

A reviewer with a financial interest in a company covered in a piece discloses it and recuses where the interest is material. Authorship and medical review are independent of any commercial consideration, as set out in our editorial policy. How we source and verify is in our methodology.

Flag a clinical concern

If you believe a clinical claim on the site is inaccurate or out of date, write to editorial@peptidewellnessusa.com. We review every flag against the source and correct the record when warranted.

Editorial note: medical review supports editorial accuracy. It is not a substitute for individual medical advice. Always consult a licensed healthcare provider familiar with your medical history. Compounded medications are not FDA-approved.